QYResearch is a leading market research publisher which pursuits high product quality with the belief that quality is the soul of business and consulting group has accumulated creative design methods on many high-quality markets investigation and research team with rich experience.
City of Industry, CA -- (SBWIRE) -- 08/10/2018 -- This report focuses on the global Oncology Molecular Diagnostics status, future forecast, growth opportunity, key market and key players. The study objectives are to present the Oncology Molecular Diagnostics development in United States, Europe and China.
Molecular diagnostics is one of the most transformative and dynamic areas of diagnostics. It is a technique used for analyzing biological markers in proteome and genome. Molecular diagnostics tests are increasingly used in oncology, infectious disease, pharmacogenomics, and human leukocyte antigen typing.
Oncology molecular diagnostics is a major application of molecular biology and is increasingly used for cancer screening, therapy selection, diagnosis, and relapse monitoring. Some of the major that are diagnosed and treated by molecular diagnostics are breast, ovarian, cervical, head and neck, pancreatic, colorectal, brain, prostate, lung, and endometrial cancers.
The key players covered in this study
Abbott Laboratories
Bayer Healthcare
Beckton Dickinson
Cepheid
Dako
Danaher
Gen Probe
Qiagen
Roche Diagnostics
Siemens
Sysmex
Market segment by Type, the product can be split into
PCR
INAAT
DNA sequencing & NGS
In situ hybridization
DNA microarrays
Other
Market segment by Application, split into
Infectious diseases
oncology
Genetic tests
Other
Market segment by Regions/Countries, this report covers
United States
Europe
China
Japan
Southeast Asia
India
Central & South America
Request Sample Copy of Report@ https://www.qyresearch.com/sample-form/form/659853/global-oncology-molecular-diagnostics-market
The study objectives of this report are:
To analyze global Oncology Molecular Diagnostics status, future forecast, growth opportunity, key market and key players.
To present the Oncology Molecular Diagnostics development in United States, Europe and China.
To strategically profile the key players and comprehensively analyze their development plan and strategies.
To define, describe and forecast the market by product type, market and key regions.
In this study, the years considered to estimate the market size of Oncology Molecular Diagnostics are as follows:
History Year: 2013-2017
Base Year: 2017
Estimated Year: 2018
Forecast Year 2018 to 2025
Request to Buy Full Report@ https://www.qyresearch.com/settlement/pre/daf098352046e8db1bb0c3c2db7145eb,0,1
About QY Research
QY Research established in 2007, focus on custom research, management consulting, IPO consulting, industry chain research, data base and seminar services. The company owned a large basic data base (such as National Bureau of statistics database, Customs import and export database, Industry Association Database etc), expert's resources (included energy automotive chemical medical ICT consumer goods etc.